EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,711 | -96.7% | 88 | -95.1% | 0.00% | -100.0% |
| Q1 2023 | $51,407 | +106.4% | 1,812 | +112.7% | 0.01% | +66.7% |
| Q4 2022 | $24,904 | +55.6% | 852 | +41.5% | 0.00% | +50.0% |
| Q3 2022 | $16,000 | +433.3% | 602 | +937.9% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 58 | -54.0% | 0.00% | -100.0% |
| Q1 2022 | $6,000 | +200.0% | 126 | +162.5% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 48 | +9.1% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 44 | +144.4% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 18 | -50.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 36 | +80.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 20 | +25.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |